COVID-19

COVID-19, Infectious Diseases

Current literature suggests that detectable antibodies against SARS-CoV-2 develop approximately 8 to 11 days following onset of symptoms. Correlation with epidemiologic risk factors and other clinical and laboratory findings is recommended. A positive serologic result is not diagnostic but indicates that an individual has likely been infected with SARS-CoV-2 and produced an immune response to the virus. It is not known at this time whether detectable antibody correlates with immunity. A negative serologic result indicates that an individual has not developed detectable antibodies at the time of testing. While contingent on a variety of factors, this could be due to testing too early in the course of infection, the absence of exposure to the virus, or the lack of adequate immune response, which can be due to conditions or treatments that suppress immune function.FDA-authorized Fact sheets for patients and providers can be accessed at the following link:https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations#covid19ivd.

COVID-19, General Health & Wellness

About 10-30% of patients continue with lingering symptoms four or more weeks after COVID-19 infection, including those who had mild, or no symptoms termed as post-COVID conditions. The Centers for Disease Control (CDC) providedInterim Guidance for Assessment and Testing for Evaluating and Caring for Patients with Post-COVID Conditions. The CDC recommends laboratory testing be guided by the patient history, physical examination, and clinical findings. A basic panel of laboratory tests might be considered for patients with ongoing symptoms to assess for conditions that may respond to treatment, until more information and evidence is available for specific laboratory testing for post-COVID conditions. This panel is to be considered for persistent symptoms if basic testing such as Complete Blood Counts, Basic Metabolic Profile, and Liver Function Tests has been completed.

COVID-19

About 10-30% of patients continue with lingering symptoms four or more weeks after COVID-19 infection, including those who had mild, or no symptoms termed as post-COVID conditions. The Centers for Disease Control (CDC) providedInterim Guidance for Assessment and Testing for Evaluating and Caring for Patients with Post-COVID Conditions. The CDC recommends laboratory testing be guided by the patient history, physical examination, and clinical findings. Specialized tests might be considered if symptoms persist for 12 weeks post COVID. This panel is to be considered for persistent symptoms to evaluate coagulation conditions.

COVID-19

About 10-30% of patients continue with lingering symptoms four or more weeks after COVID-19 infection, including those who had mild, or no symptoms termed as post-COVID conditions. The Centers for Disease Control (CDC) providedInterim Guidance for Assessment and Testing for Evaluating and Caring for Patients with Post-COVID Conditions. The CDC recommends laboratory testing be guided by the patient history, physical examination, and clinical findings. A basic panel of laboratory tests might be considered for patients with ongoing symptoms to assess for conditions that may respond to treatment, until more information and evidence is available for specific laboratory testing for post-COVID conditions. This panel is to be considered for basic testing if no previous testing was performed.

COVID-19

About 10-30% of patients continue with lingering symptoms four or more weeks after COVID-19 infection, including those who had mild, or no symptoms termed as post-COVID conditions. The Centers for Disease Control (CDC) providedInterim Guidance for Assessment and Testing for Evaluating and Caring for Patients with Post-COVID Conditions. The CDC recommends laboratory testing be guided by the patient history, physical examination, and clinical findings. Specialized tests might be considered if symptoms persist for 12 weeks post COVID. This panel is to be considered for persistent symptoms such as joint pains or rheumatological conditions.